Related Experiment Video

Updated: Apr 20, 2026

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima
09:13

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

16.1K

PMI: a ΔΨm independent pharmacological regulator of mitophagy

Daniel A East, Francesca Fagiani, James Crosby

    Chemistry & Biology
    |December 3, 2014
    PubMed

    Insights

    Researchers developed a novel compound, P62-mediated mitophagy inducer (PMI), to selectively target mitochondria for removal. This new mitophagy activator bypasses the typical PINK1/Parkin pathway, offering a safer alternative for cellular quality control.

    Area of Science:

    • Cell Biology
    • Molecular Biology
    • Biochemistry

    Background:

    • Mitophagy is crucial for maintaining mitochondrial and cellular health by removing damaged mitochondria.
    • The PINK1/Parkin pathway is the primary mechanism for mitophagy, requiring mitochondrial membrane potential (ΔΨm) loss.
    • Selective pharmacological inducers of mitophagy are scarce, limiting research and therapeutic development.

    Purpose of the Study:

    • To develop a novel pharmacological compound that selectively induces mitophagy.
    • To investigate a new mitophagy induction mechanism independent of the PINK1/Parkin pathway and ΔΨm.
    • To provide a tool for studying mitophagy and its role in cellular homeostasis.

    Main Methods:

    • Development of a compound that enhances P62/SQSTM1 expression and signaling.
    • Testing the compound's ability to induce mitophagy in cell models, including those lacking functional PINK1/Parkin.
    • Assessing the impact of the compound on mitochondrial membrane potential and cellular bio-energetics.

    Main Results:

    • The developed compound, P62-mediated mitophagy inducer (PMI), effectively induces mitophagy by upregulating P62/SQSTM1.
    • PMI activates mitophagy without requiring Parkin recruitment or loss of ΔΨm.
    • PMI retains efficacy in cells with deficient PINK1/Parkin pathways.
    • The compound selectively targets mitochondria for autophagy without compromising overall cellular energy production.

    Conclusions:

    • PMI represents a novel pharmacological tool for inducing mitophagy through a P62/SQSTM1-dependent mechanism.
    • This approach circumvents the toxicity and off-target effects associated with traditional mitophagy inducers like ionophores.
    • PMI offers a unique strategy to investigate mitophagy and its implications in cellular quality control and disease.

    More Related Videos

    Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay08:40

    Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay

    Published on: May 2, 2019

    6.4K
    In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice08:40

    In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

    Published on: November 22, 2017

    18.6K

    Related Concept Videos

    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    6.5K
    Translocation of Proteins into the Mitochondria01:19

    Translocation of Proteins into the Mitochondria

    Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
    Sorting of outer membrane proteins:
    Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
    13.8K
    Phosphoinositides and PIPs01:42

    Phosphoinositides and PIPs

    Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
    Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
    11.8K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.5K